Home » Topics » Regulatory » EMA

EMA
RSS

EMA gives Provenge a positive opinion

July 3, 2013

CHMP issues positive opinion on two variations for Velcade

July 2, 2013

Regorafenib recommended for approval in the E.U.

July 2, 2013

European CHMP recommends approval of two infliximab biosimilars

July 2, 2013

EMA recommends approval of two GSK cancer drugs

July 2, 2013

Approval of Lemtrada for relapsing remitting MS recommended in Europe

July 2, 2013

EryDex obtains orphan drug designation for ataxia telangiectasia in Europe

June 18, 2013

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

June 10, 2013

Bavarian Nordic's smallpox vaccine receives positive opinion from CHMP

June 4, 2013

Lucentis receives positive CHMP opinion in myopic choroidal neovascularization

June 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...